Neurology
RSSArticles
-
Pharmacology Watch - Full October 1, 2009 Issue in PDF
-
FDA Actions
The FDA is requiring new boxed warnings on TNF-blockers regarding the risk of lymphoma and other malignancies in children and adolescents who have received the drugs. -
Denosumab Receives Conditional Approval from FDA Expert Panel
Denosumab is a new human monoclonal antibody that suppresses osteoclast function and thus inhibits bone resorption. -
Clinical Briefs in Primary Care Supplement
-
One Hand Clapping
The hand clapping test is a quick and reliable way to screen for parietal lobe neglect syndrome. -
Value of CSF Aß/tau Profiles in Subjective and Mild Cognitive Impairment
Biomarkers in the cerebrospinal fluid may help in the early diagnosis of Alzheimer's disease. -
Anti-N-methyl-D-aspartate Receptor Encephalitis in Children and Adolescents
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis has been recognized in children as young as 23 months as well as adolescents. -
Pesticides and Parkinson's Disease
Elevated levels of a specific organochlorine pesticide are associated with Parkinson's disease. -
TMS as an Adjunct to Rehabilitation After Stroke: A Potential New Treatment
Transcranial magnetic stimulation was shown to have benefit during stroke rehabilitation therapy, in this randomized, controlled clinical trial. -
Rituximab for Neuropathy with IgM Monoclonal Gammopathy
In preliminary, open-label trials, rituximab shows promise as a treatment for IgM-associated neuropathy.